Cargando…
Cell Therapies in Bladder Cancer Management
Currently, bladder cancer (BC) represents a challenging problem in the field of Oncology. The high incidence, prevalence, and progression of BC have led to the exploration of new avenues in its management, in particular in advanced metastatic stages. The recent inclusion of immune checkpoint blockad...
Autores principales: | Morales, Lucia, Paramio, Jesús M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999326/ https://www.ncbi.nlm.nih.gov/pubmed/33802203 http://dx.doi.org/10.3390/ijms22062818 |
Ejemplares similares
-
DNA Methylation as a Therapeutic Target for Bladder Cancer
por: Nunes, Sandra P., et al.
Publicado: (2020) -
EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015) -
Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
por: Lodewijk, Iris, et al.
Publicado: (2018) -
Targeted therapies in the management of metastatic bladder cancer
por: Fassan, Matteo, et al.
Publicado: (2007) -
New and Emerging Therapies in the Management of Bladder Cancer
por: Osterman, Chelsea K., et al.
Publicado: (2020)